Mark Kirby
About
Mark Kirby has authored 28 papers that have received a total of 907 indexed citations.
This includes 15 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Oncology and 13 papers in Cellular and Molecular Neuroscience. The topics of these papers are Peptidase Inhibition and Analysis (13 papers), Diabetes Treatment and Management (13 papers) and Neuropeptides and Animal Physiology (10 papers). Mark Kirby is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Diabetes Treatment and Management (13 papers) and Neuropeptides and Animal Physiology (10 papers) and collaborates with scholars based in United States, Germany and China. Mark Kirby's co-authors include Lawrence G. Hamann, Aiying Wang, Jovita Marcinkeviciene, Carolyn A. Weigelt and Charles R. Dorso and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of the Acoustical Society of America and Biochimica et Biophysica Acta (BBA) - Biomembranes.
In The Last Decade
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Phillip N. Williams Breakdown of academic impact, for papers by Gillian Pearce Breakdown of academic impact, for papers by Philipp Wagner Breakdown of academic impact, for papers by Timothy Cheek Breakdown of academic impact, for papers by Ya‐Nan Zhao Breakdown of academic impact, for papers by Ayşenur Uğurlu Breakdown of academic impact, for papers by Xiaobin Wu Breakdown of academic impact, for papers by H.W.G.M. Boddeke